AstraZeneca
AZN
#45
Rank
C$407.68 B
Marketcap
C$131.49
Share price
0.68%
Change (1 day)
41.73%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): C$4.27

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is C$4.22. In 2024 the company made an earnings per share (EPS) of C$3.15 an increase over its 2023 EPS that were of C$2.67.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$4.2735.25%
2024C$3.1518.23%
2023C$2.6781.13%
2022C$1.47631.03%
2021C$0.20-88.11%
2020C$1.69136.89%
2019C$0.72-39.41%
2018C$1.18-28.27%
2017C$1.65-14.37%
2016C$1.9224.11%
2015C$1.55127.55%
2014C$0.68-51.96%
2013C$1.42-58.95%
2012C$3.45-32.2%
2011C$5.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Bristol-Myers Squibb
BMY
C$4.13-2.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$2.39-43.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.55 150.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$5.00 18.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
C$5.15 22.10%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
C$28.50 576.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$14.50 243.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.19 165.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$15.27 262.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$10.22 142.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland